Engineers Gate Manager LP Harvard Bioscience Inc Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 19,197 shares of HBIO stock, worth $41,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,197

Previous 18,069 6.24%

Holding current value

$41,657

Previous $51,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $2,977 - $3,993	1,128 Added 6.24%	19,197 $51,000
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $235 - $393	-85 Reduced 0.47%	18,069 $51,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $12,136 - $16,272	-3,019 Reduced 14.26%	18,154 $76,000
Q4 2023 Feb 14, 2024	SELL	$4.0 - $5.49 $33,852 - $46,461	-8,463 Reduced 28.56%	21,173 $113,000
Q3 2023 Nov 14, 2023	SELL	$4.0 - $5.82 $179,356 - $260,962	-44,839 Reduced 60.21%	29,636 $127,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $249,413 - $366,680	59,526 Added 398.19%	74,475 $408,000
Q1 2023 May 15, 2023	SELL	$2.45 - $4.22 $8,491 - $14,626	-3,466 Reduced 18.82%	14,949 $62,000
Q4 2022 Feb 14, 2023	SELL	$2.12 - $2.86 $9,635 - $12,998	-4,545 Reduced 19.8%	18,415 $51,000
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $266,265 - $447,965	-114,277 Reduced 83.27%	22,960 $59,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.42 $254,196 - $497,543	77,499 Added 129.73%	137,237 $494,000
Q1 2022 May 16, 2022	BUY	$5.16 - $7.14 $94,670 - $130,997	18,347 Added 44.33%	59,738 $371,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $32,111 - $41,235	-5,041 Reduced 10.86%	41,391 $292,000
Q3 2021 Nov 15, 2021	SELL	$6.98 - $8.47 $177,061 - $214,858	-25,367 Reduced 35.33%	46,432 $324,000
Q2 2021 Aug 16, 2021	BUY	$5.44 - $8.4 $195,584 - $302,005	35,953 Added 100.3%	71,799 $598,000
Q1 2021 May 17, 2021	BUY	$3.91 - $6.99 $85,894 - $153,556	21,968 Added 158.29%	35,846 $196,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $738 - $1,107	246 Added 1.8%	13,878 $60,000
Q3 2020 Nov 16, 2020	SELL	$2.75 - $4.2 $17,657 - $26,968	-6,421 Reduced 32.02%	13,632 $41,000
Q2 2020 Aug 17, 2020	BUY	$2.12 - $3.14 $42,512 - $62,966	20,053 New	20,053 $62,000
Q1 2020 May 15, 2020	SELL	$1.42 - $3.29 $21,072 - $48,823	-14,840 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.45 - $3.25 $19,634 - $26,045	-8,014 Reduced 35.07%	14,840 $45,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $3.47 $41,427 - $90,410	-26,055 Reduced 53.27%	22,854 $70,000
Q2 2019 Aug 14, 2019	BUY	$1.93 - $4.59 $63,715 - $151,529	33,013 Added 207.68%	48,909 $98,000
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $1,335 - $2,111	-482 Reduced 2.94%	15,896 $69,000
Q4 2018 Feb 14, 2019	SELL	$3.03 - $5.0 $15,059 - $24,850	-4,970 Reduced 23.28%	16,378 $52,000
Q3 2018 Nov 01, 2018	BUY	$5.0 - $6.65 $106,740 - $141,964	21,348 New	21,348 $112,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

31.5M

Call Options Held

700

Put Options Held

2.1K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Harvard Bioscience Inc Transaction History